Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature.

Journal of infection in developing countries 2024 Vol.18(3) p. 480-487

Eser F, Hasanoğlu İ, Kayaaslan B, Kaya Kalem A, Bilen Ş, Orhan G, Güner R

관련 도메인

Abstract

[INTRODUCTION] Iatrogenic botulism is a rare, serious disease that progresses with descending paralysis and develops after cosmetic or therapeutic botulinum toxin-A (BoNT-A) application.

[CASE PRESENTATIONS] In this case series; six cases of iatrogenic botulism followed up in our center are presented. Four of these developed after gastric BoNT-A and two after axillary BoNT-A application.

[RESULTS] The most important cause for the disease was the use of unlicensed products and high-dose toxin applications. The first symptoms were blurred vision, double vision, difficulty in swallowing, and hoarseness. Symptoms appeared within 4-10 days after the application of BoNT-A. Symptoms progressed in the course of descending paralysis in the following days with fatigue, weakness in extremities and respiratory distress. Diagnosis was based on patient history and clinical findings. The main principles of foodborne botulism therapy were applied in the treatment of iatrogenic botulism. If clinical worsening continued, regardless of the time elapsed after BoNT-A application, the use of botulinum antitoxin made a significant contribution to clinical improvement and was recommended.

[CONCLUSIONS] Routine and new indications for BoNT-A usage are increasing and, as a result, cases of iatrogenic botulism will be encountered more frequently. Physicians should be alert for iatrogenic botulism in the follow-up after BoNT-A applications and in the differential diagnosis of neurological diseases that are presented with similar findings.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 2
합병증 extremities scispacy 1
약물 high-dose toxin scispacy 1
약물 BoNT-A. scispacy 1
약물 [INTRODUCTION] scispacy 1
약물 high-dose scispacy 1
약물 BoNT-A → botulinum toxin-A scispacy 1
약물 [CONCLUSIONS] Routine scispacy 1
질환 botulism C0006057
Botulism
scispacy 1
질환 paralysis C0522224
Paralysed
scispacy 1
질환 blurred vision C0344232
Blurred vision
scispacy 1
질환 hoarseness C0019825
Hoarseness
scispacy 1
질환 Symptoms C0683368
Symptoms aspect
scispacy 1
질환 fatigue C0015672
Fatigue
scispacy 1
질환 weakness C0004093
Asthenia
scispacy 1
질환 respiratory distress C0476273
Respiratory distress
scispacy 1
질환 neurological diseases C0027765
nervous system disorder
scispacy 1
질환 gastric scispacy 1
질환 disease scispacy 1
질환 gastric BoNT-A scispacy 1
기타 axillary scispacy 1
기타 botulinum toxin-A scispacy 1
기타 BoNT-A → botulinum toxin-A scispacy 1
기타 axillary BoNT-A scispacy 1
기타 patient scispacy 1
기타 botulinum antitoxin scispacy 1

MeSH Terms

Humans; Botulinum Antitoxin; Botulinum Toxins; Botulinum Toxins, Type A; Botulism; Clostridium botulinum; Iatrogenic Disease; Paralysis

📑 인용 관계

이 논문을 인용한 후속 연구 1

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문